Effectiveness of the Valsalva Manoeuvre for reversion of supraventricular tachycardia

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 3, 2013, Pages

  Smith, Gavin D ^a   Dyson, Kylie ^b   Taylor, David ^c   Morgans, Amee ^b   Cantwell, Kate ^a  

^a MONASH UNIVERSITY   (Australia)

^b Metropolitan Ambulance Service   (Australia)

^c AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; CLINICAL EFFECTIVENESS; COMORBIDITY; COMPARATIVE EFFECTIVENESS; EMERGENCY WARD; EVIDENCE BASED MEDICINE; HUMAN; INTERNAL VALIDITY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA; SYSTEMATIC REVIEW; VALSALVA MANEUVER; META ANALYSIS; PHYSIOLOGY; TREATMENT OUTCOME;

HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TACHYCARDIA, SUPRAVENTRICULAR; TREATMENT OUTCOME; VALSALVA MANEUVER;

MLCS; MLOWN;

EID: 84880061455     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009502.pub2     Document Type: Review

References (28)

1. Lim SH, Anantharaman V, Teo WS, Goh PP, Tan AT. Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage. Annals of Emergency Medicine 1998;31(1):30-5.
2. Mehta D, Wafa S, Ward DE, Camm AJ. Relative efficacy of various physical manoeuvres in the termination of junctional tachycardia. The Lancet 1988;331(8596):1181-5.
3. Wen Z-C, Chen S-A, Tai C-T, Chiang C-E, Chiou C-W, Chang M-S. Electrophysiological mechanisms and determinants of vagal maneuvers for termination of paroxysmal supraventricular tachycardia. Circulation 1998;98:2716-23.
4. Akhtar M, Jazayeri MR, Sra J, Blanck Z, Deshpande S, Dhala A. Atrioventricular nodal reentry. Clinical, electrophysiological, and therapeutic considerations. Circulation 1993;88:282-95.
5. Carlberg DJ, Tsuchitani S, Barlotta KS, Brady WJ. Serum troponin testing in patients with paroxysmal supraventricular tachycardia: outcome after ED care. American Journal of Emergency Medicine 2011;29:545-8.
6. Delacretaz E. Supraventricular tachycardia. New England Journal of Medicine 2006;354(10):1039-51.
7. Delaney B, Loy J, Kelly AM. The relative efficacy of adenosine versus verapamil for the treatment of stable paroxysmal supraventricular tachycardia in adults: a meta-analysis. European Journal of Emergency Medicine 2011;18(3):148-52.
8. Einthoven W. The telecardiogramme [Le telecardiogramme]. Archives Internationales de Physiologie 1906;4:132-64.
9. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
10. Holdgate A, Foo A. Adenosine versus intravenous calcium channel antagonists for the treatment of supraventricular tachycardia in adults. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD005154.pub2].
11. Jellinek EH. The Valsalva manoeuvre and Antonio Valsalva (1666-1723). Journal of the Royal Society of Medicine 2006;99:448-51.
12. Junqueira LF. Teaching cardiac autonomic function dynamics employing the Valsalva (Valsalva-Weber) maneuver. Advances in Physiology Education 2007;32:100-6.
13. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
14. Loke YK, Price D, Herxheimer A. Chapter 14: Adverse effects. In: Higgins JPT, Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
15. Looga R. The Valsalva manoeuvre - cardiovascular effects and performance technique: a critical review. Respiratory Physiology & Neurobiology 2004;147:39-49.
16. McGuire MA. Paroxysmal supraventricular tachycardia: A century of progress. Lung and Circulation 2007;16:222-8.
17. Medi C, Kalman JM, Freedman SB. Supraventricular tachycardia. Medical Journal of Australia 2009;190(5):255-60.
18. Redfearn DP, Ratib K, Marshall HJ, Griffith MJ. Supraventricular tachycardia promotes release of troponin I in patients with normal coronary arteries. International Journal of Cardiology 2005;102:521-2.
19. Scheinman MM, Yang Y. The history of AV nodal reentry. Pacing and Clinical Electrophysiology (PACE) 2005;28(11):1232-7.
20. Smith G, Boyle MJ. The 10 mL syringe is useful in generating the recommended standard of 40 mmHg intrathoracic pressure for the Valsalva manoeuvre. Emergency Medicine Australasia 2009;21(6):449-54.
21. Smith G, Morgans A, Boyle M. Use of the Valsalva manoeuvre in the prehospital setting: a review of the literature. Emergency Medicine Journal 2009;26:8-10.
22. Taylor DM, Auble TF, Yealy DM. First-line management of paroxysmal supraventricular tachycardia (letter to editor). American Journal of Emergency Medicine 1999;17(2):214-6.
23. Taylor DM, Wong LF. Incorrect instruction in the use of the Valsalva manoeuvre for paroxysmal supra-ventricular tachycardia is common. Emergency Medicine 2004;16(4):284-7.
24. Vaisrub S. The Valsalva Manoeuvre in diabetic neuropathy. JAMA 1974;228(9):1151.
25. Waxman MB, Wald RW, Finley JP, Bonet JF, Downar E, Sharma AD. Valsalva termination of ventricular tachycardia. Circulation 1980;62:843-51.
26. Wellens HJJ. Twenty-five years of insights into the mechanisms of supraventricular arrhythmias. Journal of Cardiovascular Electrophysiology 2003;14:1-6.
27. Yale SH. Antonio Maria Valsalva (1666 - 1723). Clinical Medicine & Research 2005;3(1):35-8.
28. Zellweger MJ, Schaer BA, Cron TA, Pfisterer ME, Osswald S. Elevated troponin levels in the absence of coronary artery disease after supraventricular tachycardia. Swiss Medical Weekly 2003;133:439-41.